Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Head & Neck 1 Classical hematology 1 Breast 1

Conditions

Sarcoma 1 Neoplasms 1

Interventions

Radiotherapy 43 Temozolomide 34 Magnetic Resonance Spectroscopy 33 Doxorubicin 33 Specimen Handling 31 Cyclophosphamide 31 Vincristine 24 Etoposide 21 Radiation 20 Biopsy 20 Ifosfamide 19 Filgrastim 18 Sirolimus 15 Bevacizumab 15 temsirolimus 14 Sorafenib 13 X-Rays 12 Surgical Procedures, Operative 12 Nivolumab 12 Imatinib Mesylate 12 Carboplatin 12 Radiotherapy, Conformal 11 Methotrexate 11 Ipilimumab 11 Vorinostat 10 Peripheral Blood Stem Cell Transplantation 10 Irinotecan 10 Immunoglobulin G 10 Disulfides 10 Chemotherapy, Adjuvant 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × ARQ 197 × Sarcoma × Clear all

NCT01468922 2022-07-01

Pazopanib and ARQ 197 for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

32 enrolled 21 charts

Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡